1-cyclopentyl-6-(((R)-1-((S)-3-(dimethylamino)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

ID: ALA4465401

PubChem CID: 155531325

Max Phase: Preclinical

Molecular Formula: C19H29N7O2

Molecular Weight: 387.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](Nc1nc2c(cnn2C2CCCC2)c(=O)[nH]1)C(=O)N1CC[C@H](N(C)C)C1

Standard InChI:  InChI=1S/C19H29N7O2/c1-12(18(28)25-9-8-14(11-25)24(2)3)21-19-22-16-15(17(27)23-19)10-20-26(16)13-6-4-5-7-13/h10,12-14H,4-9,11H2,1-3H3,(H2,21,22,23,27)/t12-,14+/m1/s1

Standard InChI Key:  YPLXUPYIHYHJFN-OCCSQVGLSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   27.7020   -9.2615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.7020  -10.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4114  -10.4873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.4114   -8.8447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1166   -9.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1211  -10.0793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9005  -10.3265    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3793   -9.6615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8932   -9.0059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1638  -11.1032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6829  -11.7710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1710  -12.4337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9510  -12.1727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9464  -11.3515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9907  -10.4924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.2783  -10.0849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5670  -10.4945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2771   -9.2636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8546  -10.0869    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5682  -11.3158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4114   -8.0233    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7636   -9.2712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9599   -9.1025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5523   -9.8150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1000  -10.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7286   -9.8104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.3199   -9.0963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3120  -10.5159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
  7 10  1  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  1
 17 19  1  0
 17 20  2  0
  4 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 19  1  0
 24 26  1  1
 26 27  1  0
 26 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4465401

    ---

Associated Targets(Human)

PDE1B Tclin Phosphodiesterase 1B (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE9A Tchem Phosphodiesterase 9A (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 387.49Molecular Weight (Monoisotopic): 387.2383AlogP: 1.20#Rotatable Bonds: 5
Polar Surface Area: 99.15Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.57CX Basic pKa: 8.81CX LogP: 0.18CX LogD: -1.13
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.80Np Likeness Score: -1.73

References

1. Wu Y, Zhou Q, Zhang T, Li Z, Chen YP, Zhang P, Yu YF, Geng H, Tian YJ, Zhang C, Wang Y, Chen JW, Chen Y, Luo HB..  (2019)  Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia.,  62  (8): [PMID:30916555] [10.1021/acs.jmedchem.8b01041]

Source